Sales & Marketing Unlocking impact and growth at times of demerger Pharma and medtech companies have undergone unprecedented growth through aggressive M&A over the
News Roche's Gazyva breaks new ground in lupus Already approved for kidney damage in lupus, Roche's Gazyva could be heading for broader use in the potentially life-threatening autoimmune disorder.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
